177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

NCT03647657 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Basel, Switzerland

Collaborators